You will likely be eligible to switch to a different GLP-1 medication if you are already getting treatment from us, however, our doctors will always check if the medication you want to switch to is right for you
The top 5 companies in the cardiovascular drugs industry account for approximately 70% of the market share, including Pfizer, Novartis, AstraZeneca, Bayer, and Johnson & Johnson
It simultaneously activates: GLP-1 appetite & cravings control GIP metabolic regulation Glucagon increases calorie burning & fat mobilization This three-lane approach makes Retatrutide fundamentally different from other medications, potentially placing it closer to bariatric-surgery outcomes but without surgery
They need to be metabolized to work, Dr
Maybe it even crept back up a pound or two